3646 results for «740»
3646 results
DCB: does coating morphology matter for distal embolisation and clinical outcomes?
20 May 2026 – From EuroPCR 2026
Drug-coated balloon (DCB) therapy continues to evolve, with increasing attention on how coating design may influence drug transfer, vessel response and downstream clinical outcomes.
This EuroPCR 2026 session examines the role of coating morphology, comparing amorphous and crystalline technologies and their implications for drug delivery efficiency and...
All we need to know about vulnerable plaque
19 May 2026 – From EuroPCR 2026
Understand the critical importance of vulnerable plaque identification and management. This session covers optimal strategies for detecting vulnerable plaques, their prognostic implications, and evidence-based treatment approaches illustrated through detailed case presentations.
Next generation TAVI procedural planning
19 May 2026 – From EuroPCR 2026
Explore the forefront of TAVI procedural planning, featuring innovations such as valve-in-valve techniques for sutureless valves, integration of artificial intelligence in heart team decisions, and advanced imaging-guided access methods. The session also examines clinical outcomes related to bicuspid anatomy and prosthesis-patient mismatch, providing a comprehensive view...
MagicTouch sirolimus-coated balloon for coronary artery disease and peripheral artery disease treatment: where evidence meets experience
20 May 2026 – From EuroPCR 2026
This session examines the clinical evidence and experiential insights regarding the MagicTouch sirolimus-coated balloon (SCB) for treating coronary and peripheral artery disease. It reviews long-term comparative data versus paclitaxel-coated balloons, application techniques, integration into current practices, and findings from major trials such as SIRONA and SIMPLE-DM,...
Selecting PCI devices in specific scenarios
19 May 2026 – From EuroPCR 2026
This session addresses device selection strategies tailored to specific interventional cardiology scenarios. It covers innovative approaches such as coronary laser use in difficult lesions, intravascular imaging-guided treatments for in-stent restenosis, and physiological assessment post-magnesium scaffold resorption, supported by real-world data and emerging machine learning applications.
Angiography-based physiology: time to change your routine clinical practice?
20 May 2026 – From EuroPCR 2026
This session offers a critical appraisal of angiography-based physiology, with a focus on virtual fractional flow reserve (vFFR) technology. It reviews the latest clinical evidence, including insights from the FAST study programme and the FAST III randomised controlled trial. Gain a clear understanding of current guideline...
Beyond visualisation: the value and future of 4D intracardiac echocardiography in tricuspid repair and replacement
20 May 2026 – From EuroPCR 2026
Explore the transformative role of 4D intracardiac echocardiography in guiding tricuspid edge-to-edge repair (TEER) and valve replacement for tricuspid regurgitation. This session highlights how real-time, high-resolution imaging enhances procedural efficiency and safety, reducing reliance on general anesthesia and shortening procedure times compared to traditional imaging modalities.
Where to leave less behind: non-invasive CT and angiography-derived physiology for DCB lesion selection
20 May 2026 – From EuroPCR 2026
This session elucidates the role of non-invasive coronary CT and angiography-derived physiology in guiding lesion selection for drug-eluting balloon PCI. It emphasises integrating anatomical and physiological data to refine lesion preparation, strategy, and validation beyond angiography, and identifies scenarios where DEB PCI may not be optimal,...
New evidence in the treatment of calcified lesions
19 May 2026 – From EuroPCR 2026
This session presents the latest evidence on treating calcified coronary lesions, comparing intravascular lithotripsy, cutting balloons, rotational and orbital atherectomy. It includes clinical trial data on efficacy, safety, and impact on coronary microvascular function, providing a robust foundation for evidence-based decision-making in calcified lesion management.
Reshaping what's possible in complex PCI with advanced sirolimus technology
21 May 2026 – From EuroPCR 2026
Focused on advancing complex PCI, this session explores strategies to minimise metal use through advanced sirolimus technologies and drug-coated balloon (DCB) therapies. It highlights the biological and pharmacokinetic characteristics of DCBs, key device design considerations, and practical approaches to less-metal PCI. Clinical cases illustrate challenges such...
TAVI procedural complications - Part 1: VSD, valve embolisation, and more
19 May 2026 – From EuroPCR 2026
This session focuses on the complex complications that can arise during TAVI procedures, such as ventricular septal defects, valve embolisation, and other critical events. Through detailed case analyses, it offers strategies for recognition, prevention, and management to improve patient safety and outcomes.
Innovations in vascular therapies
19 May 2026 – From EuroPCR 2026
Discover cutting-edge innovations in vascular therapies highlighting novel technologies such as Pulse Intravascular Lithotripsy (IVL) for calcium modification and Amplitude Vascular Systems. The session also presents drug-free restenosis control strategies via CD31 camouflage coating promoting physiological-grade healing, emphasizing emerging solutions aimed at improving vascular intervention outcomes.
RESIL-Card in action: early European experience and lessons from the first users
19 May 2026 – From EuroPCR 2026
This session presents the early European experience with the RESIL-Card tool, designed to optimize interventional cardiology care pathways during crises. It includes practical insights from early adopters, updates on dissemination efforts across Europe, strategies for engaging patients and organizations, and discussions on national and EU political...
Aortic paravalvular leak unmasked: different faces, different strategies
19 May 2026 – From EuroPCR 2026
Examine diverse clinical scenarios and management strategies for aortic paravalvular leaks (PVL), including complex percutaneous closures post-TAVI and surgical interventions. This session presents challenging cases demonstrating varied presentations and approaches such as mechanical valve loop utilization, highlighting the complexities and tailored solutions required for successful PVL...
What bench testing teaches us about real world PCI
19 May 2026 – From EuroPCR 2026
This session explores bench testing insights into real-world percutaneous coronary interventions (PCI). Topics include comparative expansion ratios of coronary stents, prognostic assessments after drug-coated balloon treatments, mechanical performance of magnesium scaffolds in bifurcations, preclinical safety and computational modeling of bioresorbable polymer-coated stents, and evaluations of commonly...
Imaging-driven decision making in PCI for calcified lesions
19 May 2026 – From EuroPCR 2026
Focus on imaging-guided decision making in PCI for heavily calcified coronary lesions. This session includes case studies illustrating advanced techniques to navigate and treat challenging calcific anatomies, emphasizing the role of imaging modalities and atherectomy devices to optimize procedural success in complex settings such as left...
Complication management in CTO PCI - Part 1
19 May 2026 – From EuroPCR 2026
This session addresses complication management during chronic total occlusion (CTO) percutaneous coronary interventions. It covers strategies for unexpected coronary complications, managing tamponade without visible perforation, rescue techniques for atherectomy-related perforations, managing dry pericardial tamponade after septal branch perforation, and challenges when retrograde approaches encounter thrombosis in...
TAVI procedural complications - Part 2: devices issues, access-related complications and more
19 May 2026 – From EuroPCR 2026
Delve into procedural challenges encountered during TAVI, focusing on device-related issues, access complications, and bailout strategies. This session reviews real-world cases such as balloon retention, valve expansion failure, TAV-in-TAV interventions, and transcaval access lessons, providing critical insights to manage and mitigate procedural complications effectively.
CTO PCI: technical developments
19 May 2026 – From EuroPCR 2026
This session highlights technical developments in CTO PCI, featuring comparative insights from the ONUBA-CTO study on retrograde versus antegrade approaches, sex-based differences in long-term outcomes, management of balloon-undilatable lesions, the role of virtual reality audiovisual distraction, the impact of core laboratory feedback with OCT, and contemporary...
Complex PCI in patients with acute coronary syndrome
19 May 2026 – From EuroPCR 2026
Explore complex PCI management in acute coronary syndrome patients through detailed case presentations illustrating complication handling and bailout techniques. Learn from challenging scenarios including graft perforation, no-flow situations, guidewire dissections, and stent dislodgement, emphasizing preparedness and strategic responses to improve clinical outcomes in high-risk interventions.
